VIMTA LABS
Back to Income Statement
|
VIMTA LABS Last 5 Year Revenue History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Net Sales | ₹318 Cr | ₹318 Cr | ₹278 Cr | ₹211 Cr | ₹181 Cr |
What is the latest Revenue of VIMTA LABS ?
| Year | Revenue |
|---|---|
| Mar2024 | ₹318 Cr |
| Mar2023 | ₹318 Cr |
| Mar2022 | ₹278 Cr |
| Mar2021 | ₹211 Cr |
| Mar2020 | ₹181 Cr |
How is Revenue of VIMTA LABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2024 | ₹318 Cr | 0.02 | |
| Mar2023 | ₹318 Cr | 14.34 | |
| Mar2022 | ₹278 Cr | 32.09 | |
| Mar2021 | ₹211 Cr | 16.58 | |
| Mar2020 | ₹181 Cr | - | |
Compare Revenue of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹1,988.9 Cr | 3.5% | 4.7% | -1.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,855.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,550.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,906.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,632.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,427.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | 3.5% |
4.7% |
-1.3% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses